Please login to the form below
Menarini
This page shows the latest Menarini news and features for those working in and with pharma, biotech and healthcare.
EC approves Menarini Group’s Orserdu for advanced or metastatic breast cancer
The European Commission (EC) has approved the Menarini Group’s Orserdu (elacestrant) as a monotherapy for certain patients with advanced or metastatic breast cancer, Menarini and its subsidiary Stemline Therapeutics announced. ... Elcin Barker Ergun,
Latest news
-
NewAmsterdam Pharma and Frazier LifeSciences announce merger agreement
The proceeds from this transaction, combined with the upfront payment of $123m received from NewAmsterdam’s recently announced licensing agreement with the Menarini Group and the company’s existing cash, would
-
The IMC unites health industry professionals to combat antibiotic resistant infections
the British Society for Antimicrobial Chemotherapy (BSAC), Menarini UK, Pfizer UK, Roche Diagnostics UK, Thermo Fisher Scientific and the UK Sepsis Trust.
-
New cancer meds and drug extensions top CHMP recommendations
This includes Adenuric, blockbuster oncology treatment Avastin (bevacizumab) from Roche; AbbVie's auto-inflammatory drug Humira (adalimumab), Menarini's gout drug Adenuric, (febuxostat), the rare disease drug for kidney disease Soliris
-
Campaigns recognised at German health comms awards
Among the winners was Schmittgall, which picked up two awards, including the disease awareness prize for its TheraKey project for Berlin Chemie, a subsidiary of Italy's Menarini.
-
Menarini launches urology campaign in Greece
PE information push includes Not Just A Moment website. Menarini is supporting a new awareness initiative to educate men about premature ejaculation.
More from news
Approximately 5 fully matching, plus 24 partially matching documents found.
Latest Intelligence
-
Pharma deals in April 2015
Dr Reddy's, Menarini and Cipher Pharmaceuticals have acquired or licensed rights to products in South Asia, Asia Pacific (ex-Japan) and North America and Mexico, respectively. ... Menarini AP will be responsible for the clinical development, regulatory
-
Medius Deal Watch table for April 2015
120. 4SC AG/Menarini. Licensing and development agreement. Resminostat (oral HDAC) for hepatocellular carcinoma.
-
Deal Watch table for July 2013
130‡. Vivus / Berlin-Chemie (Menarini). Licence, commercialisation, supply. Spedra (avanafil) for erectile dysfunction (approved).
-
Pharma investment in Indonesia
Two years prior to its acquisition by the Italian Menarini group in Dec 2012, the Invida Group acquired 70 per cent stake of Indonesian pharmaceutical manufacturer MUGI.
-
Pharma deals during October 2012
Whilst Oxford BioTherapeutics will be responsible for the discovery activities, Menarini will lead on the manufacture and clinical development of each programme. ... Whilst no financial terms have been disclosed, a quotation from Menarini states that the
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Life wins at the Rx Club Show
Menarini. Life also picked up 6 awards of excellence in the print category for Life self-promotion and for clients Galderma and Abbott.
More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
- CDC awards over $23m to Johns Hopkins Center for Health Security project
- Looking to start activity on a currently unpromoted pharmaceutical brand?
- Considering a portfolio review?
No results were found
PMHub
COUCH Health
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
